These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31099768)

  • 21. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.
    Taylor Z; Nolan CM; Blumberg HM; ; ;
    MMWR Recomm Rep; 2005 Nov; 54(RR-12):1-81. PubMed ID: 16267499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated Tuberculosis Screening Guidelines for Health Care Personnel.
    Foster-Chang S; Balmer J
    Workplace Health Saf; 2020 Jul; 68(7):356. PubMed ID: 32364027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First assessment of interferon gamma release assay results among healthcare workers at a general hospital in China.
    Guo LP; Jiang Y; Liu YM; Cao B
    Clin Respir J; 2018 Nov; 12(11):2581-2589. PubMed ID: 30232836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
    Campbell JR; Krot J; Elwood K; Cook V; Marra F
    Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Care Screening and Treatment for Latent Tuberculosis Infection in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Kahwati LC; Feltner C; Halpern M; Woodell CL; Boland E; Amick HR; Weber RP; Jonas DE
    JAMA; 2016 Sep; 316(9):970-83. PubMed ID: 27599332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
    Mirzazadeh A; Kahn JG; Haddad MB; Hill AN; Marks SM; Readhead A; Barry PM; Flood J; Mermin JH; Shete PB
    PLoS One; 2021; 16(4):e0249012. PubMed ID: 33793612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
    Haukaas FS; Arnesen TM; Winje BA; Aas E
    Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon Gamma Release Assay versus Tuberculin Skin Testing among Healthcare Workers of Highly Diverse Origin in a Moderate Tuberculosis Burden Country.
    Al Hajoj S; Varghese B; Datijan A; Shoukri M; Alzahrani A; Alkhenizan A; AlSaif A; Althawadi S; Fernandez G; Alrajhi A
    PLoS One; 2016; 11(5):e0154803. PubMed ID: 27148876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
    Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
    BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting.
    Sharma SK; Vashishtha R; Chauhan LS; Sreenivas V; Seth D
    PLoS One; 2017; 12(1):e0169539. PubMed ID: 28060926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculin skin test - Outdated or still useful for Latent TB infection screening?
    Gualano G; Mencarini P; Lauria FN; Palmieri F; Mfinanga S; Mwaba P; Chakaya J; Zumla A; Ippolito G
    Int J Infect Dis; 2019 Mar; 80S():S20-S22. PubMed ID: 30738186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of Quantiferon-TB Gold and tuberculin skin test in patients with tuberculosis, close contact of patients, health care workers and tuberculosis laboratory personnel].
    Cesur S; Hoca NT; Tarhan G; Cimen F; Ceyhan I; Annakkaya AN; Aslan T; Birengel S
    Mikrobiyol Bul; 2010 Oct; 44(4):553-60. PubMed ID: 21063967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis Testing and Latent Tuberculosis Infection Treatment Practices Among Health Care Providers - United States, 2020-2022.
    Caruso E; Mangan JM; Maiuri A; Bouwkamp B; DeLuca N
    MMWR Morb Mortal Wkly Rep; 2023 Nov; 72(44):1183-1189. PubMed ID: 37917562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay.
    Jong Lee K; Ae Kang Y; Mi Kim Y; Cho SN; Wook Moon J; Suk Park M; Kyu Kim S; Chang J; Sam Kim Y
    Scand J Infect Dis; 2010 Sep; 42(9):672-8. PubMed ID: 20482459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing an Interferon Gamma Release Assay with the Tuberculin Skin Test During Pregnancy: Implications for Tuberculosis Screening During Prenatal Care.
    Molina R; Venkatesh K; Schantz-Dunn J; Meadows A; Nour N; Diouf K
    Matern Child Health J; 2016 Jun; 20(6):1314-20. PubMed ID: 26645617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specificity of the tuberculin skin test and the T-SPOT.TB assay among students in a low-tuberculosis incidence setting.
    Talbot EA; Harland D; Wieland-Alter W; Burrer S; Adams LV
    J Am Coll Health; 2012; 60(1):94-6. PubMed ID: 22171735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee.
    Cain KP; Garman KN; Laserson KF; Ferrousier-Davis OP; Miranda AG; Wells CD; Haley CA
    Am J Respir Crit Care Med; 2012 Aug; 186(3):273-9. PubMed ID: 22561962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.